Viewing data from:

AZLIN

ANDA

AZLOCILLIN SODIUM | A062417 | BAYER PHARMACEUTICALS CORP

3 strengths0 unique patents0 unique exclusivities

Products (3)

Sort:

#001 — EQ 2GM BASE/VIAL

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Oct 12, 1982

No patent or exclusivity listings for this strength.

#002 — EQ 3GM BASE/VIAL

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Oct 12, 1982

#003 — EQ 4GM BASE/VIAL

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Oct 12, 1982